Lawrence A. Kenyon
2021
In 2021, Lawrence A. Kenyon earned a total compensation of $2.7M as Executive Vice President, Chief Financial Officer, Treasurer and Corporate Secretary at Outlook Therapeutics, a 125% increase compared to previous year.
Compensation breakdown
| Bonus | $212,500 |
|---|---|
| Option Awards | $2,008,035 |
| Salary | $425,000 |
| Other | $23,679 |
| Total | $2,669,214 |
Kenyon received $2M in option awards, accounting for 75% of the total pay in 2021.
Kenyon also received $212.5K in bonus, $425K in salary and $23.7K in other compensation.
Rankings
In 2021, Lawrence A. Kenyon's compensation ranked 4,890th out of 12,415 executives tracked by ExecPay. In other words, Kenyon earned more than 60.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,890 out of 12,415 | 61st |
Division Manufacturing | 2,048 out of 5,505 | 63rd |
Major group Chemicals And Allied Products | 867 out of 2,375 | 64th |
Industry group Drugs | 777 out of 2,096 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 196 out of 449 | 56th |
Source: SEC filing on January 27, 2022.
Kenyon's colleagues
We found three more compensation records of executives who worked with Lawrence A. Kenyon at Outlook Therapeutics in 2021.